Coherus BioSciences, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 2 3 31 30 190 2 2 356 476 327 211 257 267
Przychód Δ r/r 0.0% 44.9% 1030.7% -3.4% 532.8% -99.2% 0.0% 22783.7% 33.6% -31.4% -35.4% 21.9% 3.8%
Marża brutto 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 95.2% 92.1% 82.4% 66.8% 36.7% 100.0%
EBIT (mln) -39 -36 -65 -219 -116 -232 -204 108 156 -264 -257 -193 -112
EBIT Δ r/r 0.0% -6.6% 79.7% 238.7% -47.1% 100.2% -11.9% -152.7% 45.1% -268.8% -2.6% -24.8% -42.2%
EBIT (%) -2028.3% -1308.4% -207.9% -729.2% -61.0% -14918.8% -13137.3% 30.3% 32.9% -80.8% -121.7% -75.1% -41.8%
Koszty finansowe (mln) 2 5 4 0 8 10 10 18 21 23 32 41 -27
EBITDA (mln) -31 -48 -83 -224 -120 -229 -200 110 157 -264 -253 -189 -112
EBITDA(%) -1647.3% -1742.6% -267.7% -745.3% -63.0% -14700.1% -12835.8% 31.0% 33.0% -80.9% -119.9% -73.6% -41.8%
Podatek (mln) 9 -7 -15 -7 1 9 5 3 3 19 35 -0 0
Zysk Netto (mln) -33 -54 -87 -223 -127 -238 -209 90 132 -306 -327 -238 29
Zysk netto Δ r/r 0.0% 62.4% 62.5% 156.2% -43.0% 87.0% -12.1% -142.9% 47.2% -331.6% 6.6% -27.2% -112.0%
Zysk netto (%) -1738.7% -1949.7% -280.1% -743.2% -67.0% -15306.6% -13453.7% 25.2% 27.8% -93.8% -154.8% -92.5% 10.7%
EPS -1.83 -2.97 -10.64 -6.01 -3.04 -4.48 -3.22 1.29 1.85 -4.06 -4.21 -2.53 0.25
EPS (rozwodnione) -1.83 -2.97 -10.64 -6.01 -3.04 -4.48 -3.22 1.23 1.62 -4.06 -4.21 -2.53 0.25
Ilośc akcji (mln) 18 18 8 37 42 53 65 70 71 75 78 94 115
Ważona ilośc akcji (mln) 18 18 8 37 42 53 65 73 83 75 78 94 115
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD